Status
Conditions
About
The purpose of this study is to determine if there is a drop in platelet count after hemodialysis. Hemodialysis membranes are known to activate complement and cause a drop in platelets and sometimes in white blood cells. The investigators are going to study one of the membranes which is the Fresenius Optiflux® to check if it causes a drop in platelets.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Hematological Cancers
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal